Automation index
How much of a Process engineer’s job can AI already do?
A diagram and a balance come earlier. Stopping the plant and not overloading the reactor do not.
This percentage does not predict how many people will lose their jobs.
Task comparison
IS WORK OVER?
Process engineer
26%
AI can already do 26% of this job.
#210 / 643
View rankingProcess engineer
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
P&IDs, balances and the operating procedure.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 48% | +8.6 |
Plant, trials and the real bottleneck.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Capacity, yields and the improvement report.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 40% | +6.4 |
Start-up, shutdown and the shift that skips the SOP.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 18% | +2.9 |
Process safety and the HAZOP that hurts.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 14% | +2.5 |
Not overloading the reactor, and signing the change.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 12% | +1.9 |
| Total | 100% | 26% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- P&IDs
- mass balances
- HAZOP
- plant start-up
- improve yields
- SOP
- bottlenecks
- process safety
Sources for this job· O*NET 17-2112.00· ESCO/ISCO 2141
IS WORK OVER?
Immunologist
27%
#168 / 643
View rankingImmunologist
Where the time goes
Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.
The time saving for each task is estimated separately.
| Task | Share | AI | Points |
|---|---|---|---|
Panel, autoantibodies and the report.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 48% | +8.6 |
Clinic, the flare and the one that does not fit.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 40% | +6.4 |
Immunosuppressant, the dose and not dropping extra.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 22% | +3.5 |
Infection, the risk and vaccinating on time.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 28% | +4.5 |
The internist, the board and not delaying the biologic.EstimateNo public source provides a precise figure. This is our estimate. | 18% | 14% | +2.5 |
Call it autoimmune, and sign the treatment.EstimateNo public source provides a precise figure. This is our estimate. | 16% | 12% | +1.9 |
| Total | 100% | 27% |
Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low
Skills and activities
- autoantibodies
- autoimmune flares
- immunosuppressants
- biologics
- vaccinate the immunocompromised
- immunology clinic
- opportunistic infections
- immune panels
Sources for this job· O*NET 29-1229.00· ESCO/ISCO 2212